SITC 40th Anniversary: I-O Progress and Potential

In celebration of the 40^th Anniversary of the Society for Immunotherapy of Cancer (SITC), the Journal for ImmunoTherapy of Cancer (JITC) presents this special series of commentaries from luminaries in the field of immuno-oncology. Numerous SITC Fellows of the Academy of Immuno-Oncology and Richard V. Smalley Memorial Award recipients put pen to paper to provide their insights into current achievements in various areas of the field while also sharing their personal, forward-looking vision of where the field is moving in the upcoming decades. As SITC looks forward with anticipation of exciting new developments, JITC aims to deepen the science of cancer immunology and immunotherapy, disseminating cutting-edge research that lays the foundation for clinical advances. Together, the vision is to catalyze the expansion of the proportion of cancer patients that receive clinical benefit and good quality of life with effective immunotherapies, aiming for 100 regulatory approvals in the next decade. “SITC 40^th Anniversary: I-O Progress and Potential” will form a roadmap to the future of I-O that touches on areas of opportunity while also celebrating 40 years of SITC driving breakthroughs in cancer immunotherapy. Get an early look at what is ahead for the series below and check back throughout 2025.